Case Study: Launching a new molecule for a rare disease
By Innomar Strategies
The challenge
How do you launch a new rare disease infusion product in a country where you have never launched a product before?
A U.S.-based company with no prior experience in the Canadian market came to Innomar-Strategies with this challenge.
Enter your information below to download the case study.
Topics:
Commercialization
Regulatory
